Why Durham biotech’s pivot means smaller, leaner company


Precision BioSciences has sold its lead cell therapy asset as the company shifts focus exclusively to gene editing.

Previous Lifepoint Health sells stake in Louisville-based Clark Memorial Health and Scott Memorial Health
Next Worthington Bank taps leader as it expands into Denton